Array BioPharma Investigative Site

Barcelona, Catalonia 08036

0 studies enrolling now · 2 studies all time

What they study most

AML, Advanced and Selected Solid Tumors, High Risk and Very High Risk MDS, Metastatic Colorectal Cancer

Studies at this site

• Study of WNT974 in Combination With LGX818 and Cetuximab in Patients With BRAF-mutant Metastatic Colorectal Cancer (mCRC) and Wnt Pathway Mutations — Completed
• A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors — Completed